Table 1: Baseline characteristics of study patients (N = 239).

Characteristic

Amlodipine Group

n = 121

Lisinopril Group

n = 118

p-value

Females, n (%)

84 (69.4)

71 (60.2)

0.134

Age (years)

60.7 ± 11.8

59.0 ± 12.1

0.270

Age groups (years), n (%)

 18-39

 40-54

 55-64

 ≥ 65

 

5 (4.1)

28 (23.1)

40 (33.1)

48 (39.7)

 

5 (4.2)

36 (30.5)

43 (36.4)

34 (28.8)

 

0.326

Marital status, n (%)

 Single

 Married

 Divorced/Widowed

 

10 (8.3)

64 (52.9)

45 (38.1)

 

10 (8.5)

63 (53.4)

45 (38.1)

 

0.993

Occupation, n (%)

 Employed

 Business

 Unemployed

 

12 (9.9)

35 (28.9)

74 (61.2)

 

13 (11.0)

44 (37.3)

61 (51.7)

 

0.320

Alcohol consumption, n (%)

16 (13.2)

13 (11.0)

0.602

Smokers, n (%)

7 (5.8)

10 (8.5)

0.419

Diabetics, n (%)

15 (12.4)

15 (12.7)

0.941

History of heart failure, n (%)

23 (19.0)

19 (16.1)

0.555

History of kidney failure, n (%)

1 (0.8)

5 (4.2)

0.092

History of stroke, n (%)

8 (6.6)

6 (5.1)

0.615

Body Mass Index (kg/m2)

29.2 ± 6.2

28.2 ± 5.5

0.191

Obesity status, n (%)

 Normal weight

 Overweight

 Obese

 

30 (25.0)

46 (38.3)

44 (36.7)

 

40 (33.9)

43 (36.4)

35 (29.7)

 

0.281

Waist circumference (cm)

96 ± 12

94 ± 11

0.134

Central obesity, n (%)

64 (52.9)

56 (47.5)

0.401

Baseline Systolic BP (mmHg)

173 ± 19

169 ± 15

0.088

Baseline Diastolic BP (mmHg)

101 ± 10

101 ± 11

0.992

Hypertension stage at baseline, n (%)

 Stage 2

 Stage 3

 

78 (64.5)

43 (35.5)

 

84 (71.2)

34 (28.8)

 

0.266

Results are mean ± SD unless stated otherwise; p-values comparison between Amlodipine and Lisinopril treatment groups.